March 3, 2021
Here is the link.
Athenex
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of various therapies for the treatment of cancer and related conditions in North America and Asia.
7 day return -54.8%
One year return -58.3%
Current price: $5.38, fair value $149.62
Dec. 30, 2021
US $138.583m/ year, 9 analysts - March 01, 2021
Earning -US$154.833m/ yr - 6 analysts - Mar 01, 2021
ATNX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%)
Earnings vs Market: ATNX is forecast to become profitable over the next 3 years, which is considered above average market growth.
Revenue vs market: ATNX's revenue (31.8% per year) is forecast to grow faster than the US market (10.3% per year).
High growth revenue: ATNX's revenue (31.8% per year) is forecast to grow faster than 20% per year.
No comments:
Post a Comment